Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.73 CAD | +0.70% | +0.17% | +10.40% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Evolution of the average Target Price on Knight Therapeutics Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Knight Therapeutics Inc.
RBC Capital Markets | |
National Bank | |
Stifel GMP |
EPS Revisions
- Stock Market
- Equities
- GUD Stock
- Consensus Knight Therapeutics Inc.